Pegasus Hava Tasimaciligi AS
IST:PGSUS.E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pegasus Hava Tasimaciligi AS
IST:PGSUS.E
|
TR |
|
A
|
AIM ImmunoTech Inc
AMEX:AIM
|
US |
|
Augros Cosmetic Packaging SA
PAR:AUGR
|
FR |
|
Novozymes A/S
CSE:NSIS B
|
DK |
|
Canyon Resources Ltd
ASX:CAY
|
AU |
Wall St Price Targets
PGSUS.E Price Targets Summary
Pegasus Hava Tasimaciligi AS
According to Wall Street analysts, the average 1-year price target for PGSUS.E is 311.21 TRY with a low forecast of 250.48 TRY and a high forecast of 409.5 TRY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PGSUS.E's stock price target?
Price Target
311.21
TRY
According to Wall Street analysts, the average 1-year price target for PGSUS.E is 311.21 TRY with a low forecast of 250.48 TRY and a high forecast of 409.5 TRY.
What is the Revenue forecast for Pegasus Hava Tasimaciligi AS?
Projected CAGR
-5%
Over the last 8 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 3 years is -5%.
What is the Operating Income forecast for Pegasus Hava Tasimaciligi AS?
Projected CAGR
16%
Over the last 8 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Pegasus Hava Tasimaciligi AS?
Projected CAGR
15%
Over the last 8 years, the compound annual growth rate for Net Income has been 51%. The projected CAGR for the next 3 years is 15%.
